The new Biotech and Biomanufacturing Hub, a key milestone in the European Commission’s Strategy to boost biotechnology and biomanufacturing in the EU, was officially launched on 30 January 2025. Designed as a central reference point, the Hub is accessible through the Your Europe web portal and aims to streamline the scale-up process while making it easier for businesses – particularly startups and SMEs – to navigate complex regulatory frameworks.
Companies looking to bring innovative biotech products to the EU market and enhance their competitiveness can access a comprehensive set of resources within the Hub. The platform provides essential information on regulatory pathways for human and veterinary medicines, biologicals, advanced therapy medicinal products (ATMPs), and feed and food ingredients. Additionally, it offers guidance on the authorisation process for different biotech products, intellectual property protection, and health technology assessments—all of which are crucial for ensuring market access and compliance.
Beyond regulatory insights, the Hub also serves as a gateway to EU funding opportunities, helping biotech and biomanufacturing companies identify financial support mechanisms tailored to their needs. A dedicated section highlights available research infrastructures, including pilot and testing facilities, networks, and collaborations that can support R&D and innovation activities. Moreover, companies can leverage market insights provided through the platform to make informed strategic decisions.
By consolidating all these resources into a single access point, the new Biotech and Biomanufacturing Hub represents a significant step toward fostering a more dynamic, competitive, and innovation-driven biotech sector in Europe.
Source: European Commission